Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 75 | 2024 | 9741 | 3.290 |
Why?
|
Cerebral Angiography | 33 | 2019 | 1263 | 3.170 |
Why?
|
Diffusion Magnetic Resonance Imaging | 39 | 2024 | 2808 | 2.670 |
Why?
|
Brain Ischemia | 35 | 2024 | 3001 | 2.300 |
Why?
|
Magnetic Resonance Angiography | 18 | 2019 | 1428 | 1.830 |
Why?
|
Cerebral Infarction | 20 | 2020 | 968 | 1.610 |
Why?
|
Tomography, X-Ray Computed | 58 | 2023 | 20708 | 1.380 |
Why?
|
Magnetic Resonance Imaging | 100 | 2024 | 36567 | 1.360 |
Why?
|
Radiology | 13 | 2024 | 2105 | 1.360 |
Why?
|
Brain | 82 | 2024 | 27159 | 1.360 |
Why?
|
Cerebral Arteries | 8 | 2018 | 490 | 1.020 |
Why?
|
Diagnostic Imaging | 9 | 2021 | 3531 | 1.010 |
Why?
|
Infarction | 3 | 2024 | 247 | 0.980 |
Why?
|
Cerebrovascular Disorders | 11 | 2019 | 1479 | 0.790 |
Why?
|
Triage | 6 | 2021 | 995 | 0.790 |
Why?
|
Brain Diseases | 8 | 2024 | 1552 | 0.770 |
Why?
|
Thrombolytic Therapy | 11 | 2021 | 2053 | 0.750 |
Why?
|
Cerebral Revascularization | 3 | 2013 | 260 | 0.720 |
Why?
|
Cerebrovascular Circulation | 21 | 2017 | 2672 | 0.660 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2019 | 68 | 0.630 |
Why?
|
Vascular Diseases | 3 | 2019 | 1161 | 0.620 |
Why?
|
Neuroradiography | 4 | 2016 | 71 | 0.590 |
Why?
|
Central Nervous System Diseases | 3 | 2019 | 518 | 0.570 |
Why?
|
Ischemic Attack, Transient | 8 | 2013 | 874 | 0.560 |
Why?
|
Tuberculosis, Meningeal | 2 | 2014 | 49 | 0.550 |
Why?
|
Perfusion Imaging | 6 | 2015 | 193 | 0.550 |
Why?
|
Reperfusion | 4 | 2014 | 268 | 0.550 |
Why?
|
Leadership | 3 | 2024 | 1394 | 0.520 |
Why?
|
Internship and Residency | 6 | 2023 | 5943 | 0.510 |
Why?
|
Impulsive Behavior | 1 | 2018 | 345 | 0.500 |
Why?
|
Echo-Planar Imaging | 6 | 2022 | 649 | 0.500 |
Why?
|
Neuromyelitis Optica | 1 | 2019 | 266 | 0.500 |
Why?
|
Meninges | 1 | 2017 | 197 | 0.490 |
Why?
|
Head Injuries, Closed | 3 | 2010 | 133 | 0.490 |
Why?
|
Intracranial Hemorrhages | 5 | 2023 | 810 | 0.480 |
Why?
|
Cerebral Hemorrhage | 14 | 2011 | 2654 | 0.480 |
Why?
|
Gadolinium | 8 | 2021 | 964 | 0.460 |
Why?
|
Humans | 238 | 2024 | 766766 | 0.460 |
Why?
|
Nervous System Diseases | 3 | 2019 | 1659 | 0.460 |
Why?
|
Image Interpretation, Computer-Assisted | 8 | 2020 | 3359 | 0.450 |
Why?
|
Frontal Lobe | 2 | 2018 | 1408 | 0.410 |
Why?
|
Diagnosis, Differential | 34 | 2024 | 12985 | 0.410 |
Why?
|
Glioblastoma | 5 | 2014 | 3458 | 0.410 |
Why?
|
Aged | 117 | 2024 | 171343 | 0.400 |
Why?
|
Burnout, Professional | 1 | 2021 | 710 | 0.400 |
Why?
|
Radiology Department, Hospital | 3 | 2021 | 409 | 0.400 |
Why?
|
Confusion | 6 | 2022 | 278 | 0.400 |
Why?
|
Aneurysm, Ruptured | 2 | 2015 | 455 | 0.390 |
Why?
|
Contrast Media | 18 | 2017 | 5329 | 0.380 |
Why?
|
Diffuse Axonal Injury | 4 | 2004 | 49 | 0.370 |
Why?
|
Brain Neoplasms | 13 | 2017 | 9101 | 0.360 |
Why?
|
Aged, 80 and over | 69 | 2024 | 59550 | 0.360 |
Why?
|
Intraoperative Care | 1 | 2014 | 768 | 0.350 |
Why?
|
Carotid Stenosis | 4 | 2012 | 858 | 0.340 |
Why?
|
Middle Aged | 111 | 2024 | 223257 | 0.340 |
Why?
|
Coma | 3 | 2023 | 485 | 0.340 |
Why?
|
Male | 138 | 2024 | 364142 | 0.340 |
Why?
|
Executive Function | 1 | 2018 | 1396 | 0.330 |
Why?
|
Sinus Thrombosis, Intracranial | 3 | 2010 | 111 | 0.330 |
Why?
|
Sensitivity and Specificity | 28 | 2017 | 14652 | 0.330 |
Why?
|
Image Processing, Computer-Assisted | 18 | 2024 | 8926 | 0.320 |
Why?
|
Algorithms | 11 | 2023 | 14072 | 0.310 |
Why?
|
Acute Disease | 20 | 2017 | 7241 | 0.310 |
Why?
|
Meningeal Neoplasms | 3 | 2014 | 1255 | 0.300 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 220 | 0.300 |
Why?
|
Education, Medical, Graduate | 4 | 2023 | 2418 | 0.300 |
Why?
|
Headache | 4 | 2022 | 1260 | 0.300 |
Why?
|
Skull Neoplasms | 2 | 2007 | 173 | 0.290 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 111 | 0.280 |
Why?
|
Intracranial Aneurysm | 2 | 2015 | 1271 | 0.280 |
Why?
|
Guidelines as Topic | 1 | 2014 | 1394 | 0.280 |
Why?
|
Female | 131 | 2024 | 396520 | 0.280 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2254 | 0.280 |
Why?
|
Glasgow Coma Scale | 4 | 2022 | 574 | 0.280 |
Why?
|
Image Enhancement | 8 | 2016 | 2857 | 0.270 |
Why?
|
Patient Selection | 6 | 2017 | 4252 | 0.260 |
Why?
|
Brain Infarction | 4 | 2012 | 284 | 0.260 |
Why?
|
Reproducibility of Results | 26 | 2020 | 20144 | 0.260 |
Why?
|
Brain Edema | 3 | 2022 | 601 | 0.260 |
Why?
|
Health Expenditures | 2 | 2015 | 2390 | 0.250 |
Why?
|
Radiology Information Systems | 3 | 2020 | 535 | 0.250 |
Why?
|
Thrombectomy | 3 | 2021 | 676 | 0.250 |
Why?
|
Consciousness Disorders | 2 | 2021 | 445 | 0.240 |
Why?
|
Accidental Falls | 2 | 2024 | 1078 | 0.240 |
Why?
|
Radiography | 11 | 2023 | 6968 | 0.240 |
Why?
|
Basilar Artery | 3 | 2017 | 207 | 0.240 |
Why?
|
Severity of Illness Index | 14 | 2021 | 15908 | 0.230 |
Why?
|
Webcasts as Topic | 1 | 2024 | 21 | 0.230 |
Why?
|
Neck Injuries | 2 | 2010 | 162 | 0.230 |
Why?
|
Tomography, Spiral Computed | 1 | 2006 | 273 | 0.230 |
Why?
|
Stiff-Person Syndrome | 1 | 2024 | 31 | 0.230 |
Why?
|
Fibrinolytic Agents | 2 | 2012 | 2078 | 0.220 |
Why?
|
Retrospective Studies | 39 | 2023 | 81635 | 0.220 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2011 | 1226 | 0.220 |
Why?
|
Artifacts | 9 | 2023 | 1896 | 0.220 |
Why?
|
Muscle Weakness | 4 | 2022 | 412 | 0.220 |
Why?
|
Angiography | 2 | 2009 | 1595 | 0.220 |
Why?
|
Diffusion | 10 | 2011 | 808 | 0.220 |
Why?
|
Perfusion | 6 | 2021 | 1409 | 0.220 |
Why?
|
Functional Laterality | 1 | 2010 | 2243 | 0.210 |
Why?
|
Emergency Medical Services | 1 | 2015 | 1936 | 0.210 |
Why?
|
Personnel Selection | 1 | 2005 | 201 | 0.210 |
Why?
|
Fatal Outcome | 10 | 2022 | 1838 | 0.210 |
Why?
|
Glioma | 3 | 2014 | 3498 | 0.210 |
Why?
|
Eclampsia | 2 | 2009 | 61 | 0.210 |
Why?
|
Blood Volume | 4 | 2012 | 544 | 0.210 |
Why?
|
Adult | 83 | 2024 | 223307 | 0.210 |
Why?
|
Health Policy | 1 | 2015 | 2698 | 0.210 |
Why?
|
Tissue Survival | 1 | 2003 | 120 | 0.210 |
Why?
|
Predictive Value of Tests | 15 | 2015 | 15416 | 0.200 |
Why?
|
West Nile Fever | 2 | 2017 | 77 | 0.200 |
Why?
|
Meningoencephalitis | 2 | 2018 | 82 | 0.200 |
Why?
|
Neuroschistosomiasis | 1 | 2001 | 3 | 0.200 |
Why?
|
Critical Care | 1 | 2015 | 2714 | 0.200 |
Why?
|
Blood Flow Velocity | 4 | 2011 | 1374 | 0.200 |
Why?
|
Artificial Intelligence | 3 | 2021 | 2662 | 0.200 |
Why?
|
Lumbar Vertebrae | 3 | 2024 | 1878 | 0.200 |
Why?
|
Imaging, Three-Dimensional | 4 | 2023 | 4047 | 0.190 |
Why?
|
Inpatients | 2 | 2024 | 2565 | 0.190 |
Why?
|
Spin Labels | 2 | 2021 | 334 | 0.190 |
Why?
|
Arterial Occlusive Diseases | 3 | 2018 | 742 | 0.190 |
Why?
|
Craniocerebral Trauma | 2 | 2010 | 493 | 0.190 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2022 | 92 | 0.190 |
Why?
|
Bipolar Disorder | 1 | 2018 | 5130 | 0.180 |
Why?
|
Leukoencephalopathies | 2 | 2021 | 258 | 0.180 |
Why?
|
Relapsing Fever | 1 | 2020 | 26 | 0.180 |
Why?
|
Borrelia | 1 | 2020 | 66 | 0.170 |
Why?
|
Mycobacterium bovis | 1 | 2021 | 148 | 0.170 |
Why?
|
Prognosis | 17 | 2023 | 29948 | 0.170 |
Why?
|
Infarction, Middle Cerebral Artery | 4 | 2012 | 484 | 0.170 |
Why?
|
Back Pain | 1 | 2024 | 547 | 0.170 |
Why?
|
Cerebral Cortex | 4 | 2014 | 5753 | 0.170 |
Why?
|
Carotid Arteries | 2 | 2018 | 932 | 0.170 |
Why?
|
Angiography, Digital Subtraction | 2 | 2019 | 331 | 0.170 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2019 | 45 | 0.160 |
Why?
|
ROC Curve | 6 | 2014 | 3620 | 0.160 |
Why?
|
Wounds, Nonpenetrating | 2 | 2010 | 807 | 0.160 |
Why?
|
Diagnostic Errors | 3 | 2015 | 1276 | 0.160 |
Why?
|
Academic Medical Centers | 5 | 2021 | 2783 | 0.160 |
Why?
|
Periodicals as Topic | 2 | 2024 | 1463 | 0.160 |
Why?
|
Fever | 4 | 2022 | 1607 | 0.160 |
Why?
|
Carcinoma | 2 | 2007 | 2324 | 0.160 |
Why?
|
Comparative Effectiveness Research | 2 | 2014 | 713 | 0.160 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2014 | 792 | 0.160 |
Why?
|
Collateral Circulation | 2 | 2017 | 289 | 0.150 |
Why?
|
Brain Injuries | 5 | 2021 | 2053 | 0.150 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7431 | 0.150 |
Why?
|
Disability Evaluation | 2 | 2009 | 1827 | 0.150 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2019 | 138 | 0.150 |
Why?
|
Persistent Vegetative State | 1 | 2020 | 274 | 0.150 |
Why?
|
Night Care | 1 | 2017 | 28 | 0.140 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2022 | 341 | 0.140 |
Why?
|
Roseolovirus Infections | 1 | 2018 | 50 | 0.140 |
Why?
|
Carotid Artery, Internal | 4 | 2015 | 440 | 0.140 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 96 | 0.140 |
Why?
|
Septins | 1 | 2016 | 47 | 0.140 |
Why?
|
Hemorrhage | 1 | 2009 | 3464 | 0.130 |
Why?
|
Microvessels | 1 | 2021 | 586 | 0.130 |
Why?
|
Software | 2 | 2009 | 4466 | 0.130 |
Why?
|
Medical Staff, Hospital | 1 | 2020 | 602 | 0.130 |
Why?
|
Educational Status | 1 | 2023 | 2510 | 0.130 |
Why?
|
Recovery of Function | 3 | 2021 | 2976 | 0.130 |
Why?
|
Blood Volume Determination | 2 | 2012 | 41 | 0.130 |
Why?
|
Follow-Up Studies | 12 | 2015 | 39309 | 0.130 |
Why?
|
Lumbosacral Region | 1 | 2017 | 294 | 0.130 |
Why?
|
Purpura | 1 | 1996 | 117 | 0.120 |
Why?
|
Encephalomyelitis, Eastern Equine | 2 | 2008 | 14 | 0.120 |
Why?
|
Regional Blood Flow | 4 | 2008 | 1478 | 0.120 |
Why?
|
Compensation and Redress | 1 | 2015 | 66 | 0.120 |
Why?
|
Hepatic Encephalopathy | 1 | 2016 | 143 | 0.120 |
Why?
|
Injections, Intra-Arterial | 2 | 2006 | 181 | 0.120 |
Why?
|
Tissue Plasminogen Activator | 3 | 2013 | 1164 | 0.120 |
Why?
|
Middle Cerebral Artery | 2 | 2015 | 271 | 0.120 |
Why?
|
Astrocytoma | 2 | 2013 | 773 | 0.120 |
Why?
|
Oxygen Inhalation Therapy | 3 | 2010 | 418 | 0.120 |
Why?
|
Brain Stem | 3 | 2014 | 858 | 0.120 |
Why?
|
Subarachnoid Hemorrhage | 2 | 1999 | 1023 | 0.120 |
Why?
|
Neck | 1 | 2019 | 735 | 0.120 |
Why?
|
Biliary Tract Neoplasms | 1 | 2016 | 186 | 0.120 |
Why?
|
Medulla Oblongata | 1 | 2016 | 247 | 0.120 |
Why?
|
Gadolinium DTPA | 2 | 2011 | 823 | 0.120 |
Why?
|
Liver Failure, Acute | 1 | 2016 | 182 | 0.120 |
Why?
|
Statistics, Nonparametric | 2 | 2010 | 2846 | 0.120 |
Why?
|
Motion | 3 | 2023 | 783 | 0.120 |
Why?
|
Renal Insufficiency | 3 | 2021 | 811 | 0.110 |
Why?
|
Endovascular Procedures | 3 | 2021 | 2215 | 0.110 |
Why?
|
Efficiency | 1 | 2017 | 479 | 0.110 |
Why?
|
Faculty, Medical | 2 | 2020 | 1226 | 0.110 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2014 | 1188 | 0.110 |
Why?
|
Cardiac Volume | 1 | 2014 | 196 | 0.110 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2022 | 996 | 0.110 |
Why?
|
Fellowships and Scholarships | 3 | 2016 | 1134 | 0.110 |
Why?
|
Paresis | 2 | 2012 | 177 | 0.110 |
Why?
|
Tomography | 1 | 1996 | 443 | 0.110 |
Why?
|
Head | 1 | 2019 | 926 | 0.110 |
Why?
|
Personality Disorders | 1 | 2018 | 727 | 0.110 |
Why?
|
Governing Board | 1 | 2013 | 50 | 0.110 |
Why?
|
Heart Arrest | 1 | 2023 | 1516 | 0.110 |
Why?
|
Hyperplasia | 2 | 2013 | 1150 | 0.110 |
Why?
|
Alcohol Withdrawal Seizures | 1 | 2012 | 10 | 0.110 |
Why?
|
United States Dept. of Health and Human Services | 1 | 2013 | 88 | 0.110 |
Why?
|
United States | 15 | 2021 | 72951 | 0.100 |
Why?
|
Leukoaraiosis | 2 | 2019 | 114 | 0.100 |
Why?
|
Alcohol Withdrawal Delirium | 1 | 2012 | 26 | 0.100 |
Why?
|
Peer Review | 1 | 2015 | 218 | 0.100 |
Why?
|
Hematoma, Subdural | 1 | 2013 | 128 | 0.100 |
Why?
|
Time Factors | 17 | 2017 | 40149 | 0.100 |
Why?
|
Cerebral Amyloid Angiopathy | 2 | 1999 | 887 | 0.100 |
Why?
|
Adolescent | 26 | 2020 | 88904 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3110 | 0.100 |
Why?
|
Immunocompromised Host | 1 | 2018 | 865 | 0.100 |
Why?
|
Pituitary Neoplasms | 2 | 2011 | 1324 | 0.100 |
Why?
|
Treatment Outcome | 18 | 2017 | 65273 | 0.100 |
Why?
|
Cerebrospinal Fluid | 3 | 2020 | 540 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3232 | 0.100 |
Why?
|
Single-Blind Method | 2 | 2014 | 1587 | 0.100 |
Why?
|
Vascular Neoplasms | 1 | 2013 | 167 | 0.100 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2013 | 141 | 0.100 |
Why?
|
Nelson Syndrome | 1 | 2011 | 20 | 0.100 |
Why?
|
Risk Factors | 14 | 2023 | 74881 | 0.100 |
Why?
|
West Nile virus | 2 | 2017 | 77 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1811 | 0.100 |
Why?
|
Young Adult | 15 | 2023 | 59939 | 0.090 |
Why?
|
Adrenal Cortex | 1 | 2011 | 134 | 0.090 |
Why?
|
Magnetics | 1 | 2014 | 586 | 0.090 |
Why?
|
Critical Pathways | 1 | 2015 | 475 | 0.090 |
Why?
|
Artificial Limbs | 1 | 2012 | 121 | 0.090 |
Why?
|
Neurodegenerative Diseases | 1 | 2020 | 1089 | 0.090 |
Why?
|
Patient Discharge | 1 | 2004 | 3465 | 0.090 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2011 | 101 | 0.090 |
Why?
|
Iopamidol | 1 | 2011 | 188 | 0.090 |
Why?
|
Observer Variation | 6 | 2012 | 2614 | 0.090 |
Why?
|
Waldenstrom Macroglobulinemia | 2 | 2011 | 1076 | 0.090 |
Why?
|
Hepatitis B | 1 | 2016 | 709 | 0.090 |
Why?
|
Malpractice | 1 | 2015 | 561 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2021 | 3799 | 0.090 |
Why?
|
Adenoma | 2 | 2011 | 2155 | 0.090 |
Why?
|
Radiation Injuries | 2 | 2010 | 1194 | 0.090 |
Why?
|
Ultrasonography | 3 | 2019 | 5992 | 0.090 |
Why?
|
Multiple Trauma | 1 | 2012 | 369 | 0.080 |
Why?
|
Child | 17 | 2019 | 80668 | 0.080 |
Why?
|
Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.080 |
Why?
|
Cerebral Veins | 1 | 2011 | 157 | 0.080 |
Why?
|
Hematoma, Subdural, Intracranial | 1 | 2009 | 30 | 0.080 |
Why?
|
Scalp | 1 | 2012 | 390 | 0.080 |
Why?
|
Meglumine | 1 | 2009 | 144 | 0.080 |
Why?
|
Advisory Committees | 1 | 2013 | 797 | 0.080 |
Why?
|
Medicare | 4 | 2015 | 6820 | 0.080 |
Why?
|
Adrenal Glands | 1 | 2011 | 556 | 0.080 |
Why?
|
Radiology, Interventional | 1 | 2013 | 483 | 0.080 |
Why?
|
Health Promotion | 1 | 2021 | 2209 | 0.080 |
Why?
|
Phlebography | 1 | 2010 | 326 | 0.080 |
Why?
|
Cerebellar Neoplasms | 1 | 2013 | 588 | 0.080 |
Why?
|
Encephalitis Virus, Eastern Equine | 1 | 2008 | 12 | 0.080 |
Why?
|
Skull Fractures | 1 | 2010 | 202 | 0.080 |
Why?
|
Hospitals, General | 1 | 2013 | 804 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1946 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2020 | 3681 | 0.070 |
Why?
|
Tuberculosis | 1 | 2021 | 2011 | 0.070 |
Why?
|
Adenocarcinoma | 3 | 2016 | 6359 | 0.070 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 479 | 0.070 |
Why?
|
Statistics as Topic | 3 | 2012 | 2351 | 0.070 |
Why?
|
Homeodomain Proteins | 1 | 2016 | 2430 | 0.070 |
Why?
|
Acromegaly | 1 | 2010 | 316 | 0.070 |
Why?
|
Accidents, Traffic | 1 | 2012 | 818 | 0.070 |
Why?
|
Lyme Neuroborreliosis | 1 | 2007 | 50 | 0.070 |
Why?
|
Communication | 1 | 2021 | 3905 | 0.070 |
Why?
|
Extremities | 1 | 2012 | 869 | 0.070 |
Why?
|
Prospective Studies | 13 | 2024 | 54871 | 0.070 |
Why?
|
Vasospasm, Intracranial | 1 | 2009 | 207 | 0.070 |
Why?
|
Hospital Mortality | 2 | 2011 | 5343 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2021 | 3229 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2903 | 0.060 |
Why?
|
Organometallic Compounds | 1 | 2009 | 647 | 0.060 |
Why?
|
Pandemics | 3 | 2021 | 8735 | 0.060 |
Why?
|
Puerperal Disorders | 1 | 2009 | 304 | 0.060 |
Why?
|
Central Nervous System Fungal Infections | 1 | 2005 | 23 | 0.060 |
Why?
|
Human Growth Hormone | 1 | 2010 | 640 | 0.060 |
Why?
|
Neurology | 1 | 2013 | 785 | 0.060 |
Why?
|
Borrelia burgdorferi | 1 | 2007 | 183 | 0.060 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2014 | 1336 | 0.060 |
Why?
|
Surgical Instruments | 1 | 2007 | 379 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 8045 | 0.060 |
Why?
|
Iohexol | 1 | 2006 | 205 | 0.060 |
Why?
|
Seizures | 4 | 2012 | 2996 | 0.060 |
Why?
|
Child, Preschool | 9 | 2019 | 42577 | 0.060 |
Why?
|
Multivariate Analysis | 3 | 2014 | 12064 | 0.060 |
Why?
|
Meningioma | 2 | 2012 | 1221 | 0.060 |
Why?
|
Aneurysm | 1 | 2007 | 343 | 0.060 |
Why?
|
Hypertension | 4 | 2019 | 8616 | 0.060 |
Why?
|
Patient Admission | 1 | 2011 | 1364 | 0.060 |
Why?
|
Infertility, Female | 1 | 2010 | 763 | 0.060 |
Why?
|
Brain Abscess | 1 | 2005 | 122 | 0.060 |
Why?
|
Health Care Reform | 1 | 2013 | 1256 | 0.060 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7871 | 0.060 |
Why?
|
Spasm | 1 | 2024 | 131 | 0.060 |
Why?
|
Hydrocortisone | 1 | 2011 | 1838 | 0.050 |
Why?
|
Encephalitis | 2 | 2017 | 441 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8717 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2004 | 265 | 0.050 |
Why?
|
Rhabdomyosarcoma, Embryonal | 1 | 2004 | 99 | 0.050 |
Why?
|
Body Water | 1 | 2004 | 337 | 0.050 |
Why?
|
Thalamus | 2 | 2000 | 1040 | 0.050 |
Why?
|
Corpus Callosum | 2 | 2005 | 751 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2005 | 11872 | 0.050 |
Why?
|
Cohort Studies | 9 | 2016 | 41710 | 0.050 |
Why?
|
Heart Ventricles | 1 | 2014 | 3832 | 0.050 |
Why?
|
Videoconferencing | 1 | 2004 | 209 | 0.050 |
Why?
|
Oligodendroglioma | 1 | 2004 | 274 | 0.050 |
Why?
|
Deoxycytidine | 2 | 2005 | 886 | 0.050 |
Why?
|
Time | 1 | 2024 | 550 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3236 | 0.050 |
Why?
|
Motor Activity | 1 | 2012 | 2711 | 0.050 |
Why?
|
Remote Consultation | 1 | 2004 | 241 | 0.050 |
Why?
|
Spectrum Analysis | 1 | 2024 | 443 | 0.050 |
Why?
|
Orbital Neoplasms | 1 | 2004 | 223 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2014 | 3935 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2012 | 9404 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16724 | 0.050 |
Why?
|
Amnesia, Transient Global | 1 | 2001 | 19 | 0.050 |
Why?
|
Biopsy | 4 | 2019 | 6779 | 0.050 |
Why?
|
Boronic Acids | 1 | 2005 | 915 | 0.050 |
Why?
|
Documentation | 1 | 2007 | 914 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2012 | 3511 | 0.050 |
Why?
|
Comorbidity | 6 | 2012 | 10580 | 0.050 |
Why?
|
Burns | 1 | 2012 | 1902 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2010 | 2028 | 0.050 |
Why?
|
Clinical Protocols | 2 | 2017 | 1437 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3692 | 0.050 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2024 | 2478 | 0.050 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2001 | 120 | 0.050 |
Why?
|
Spinal Stenosis | 1 | 2024 | 259 | 0.040 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2018 | 1642 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2024 | 6550 | 0.040 |
Why?
|
Radiotherapy, Conformal | 1 | 2004 | 545 | 0.040 |
Why?
|
False Positive Reactions | 1 | 2002 | 957 | 0.040 |
Why?
|
Medicaid | 1 | 2013 | 2836 | 0.040 |
Why?
|
Subarachnoid Space | 1 | 1999 | 78 | 0.040 |
Why?
|
Survival Rate | 3 | 2009 | 12825 | 0.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5753 | 0.040 |
Why?
|
Pyrazines | 1 | 2005 | 1204 | 0.040 |
Why?
|
Syndrome | 2 | 2009 | 3271 | 0.040 |
Why?
|
Speech Disorders | 1 | 2020 | 178 | 0.040 |
Why?
|
Metabolic Clearance Rate | 1 | 1999 | 361 | 0.040 |
Why?
|
Relative Value Scales | 1 | 2019 | 85 | 0.040 |
Why?
|
Leg | 1 | 2024 | 1087 | 0.040 |
Why?
|
Medical Records | 1 | 2004 | 1408 | 0.040 |
Why?
|
Pilot Projects | 5 | 2012 | 8728 | 0.040 |
Why?
|
Career Choice | 1 | 2005 | 768 | 0.040 |
Why?
|
Spinal Diseases | 1 | 2024 | 561 | 0.040 |
Why?
|
Occipital Lobe | 1 | 2000 | 376 | 0.040 |
Why?
|
Craniotomy | 2 | 2014 | 736 | 0.040 |
Why?
|
Massachusetts | 4 | 2013 | 8891 | 0.040 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2693 | 0.040 |
Why?
|
Intracranial Embolism | 1 | 2000 | 188 | 0.040 |
Why?
|
Mutism | 1 | 1998 | 27 | 0.040 |
Why?
|
Foscarnet | 1 | 2018 | 36 | 0.040 |
Why?
|
Aneurysm, False | 1 | 2021 | 264 | 0.040 |
Why?
|
Disease Progression | 7 | 2014 | 13640 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2010 | 283 | 0.040 |
Why?
|
Graft vs Host Reaction | 1 | 2018 | 99 | 0.040 |
Why?
|
Shock | 1 | 2020 | 316 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 764 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2022 | 634 | 0.040 |
Why?
|
Intracranial Hypotension | 1 | 1998 | 42 | 0.040 |
Why?
|
Time and Motion Studies | 1 | 2017 | 143 | 0.040 |
Why?
|
Nerve Fibers, Myelinated | 3 | 2009 | 951 | 0.040 |
Why?
|
Animals | 5 | 2017 | 168930 | 0.030 |
Why?
|
Security Measures | 1 | 2017 | 83 | 0.030 |
Why?
|
Organizational Innovation | 1 | 2020 | 540 | 0.030 |
Why?
|
Decerebrate State | 1 | 2016 | 42 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2008 | 3212 | 0.030 |
Why?
|
Attitude of Health Personnel | 2 | 2014 | 3927 | 0.030 |
Why?
|
Calcinosis | 2 | 2009 | 1480 | 0.030 |
Why?
|
Schistosomiasis mansoni | 1 | 1997 | 94 | 0.030 |
Why?
|
Prevalence | 5 | 2012 | 15835 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2001 | 668 | 0.030 |
Why?
|
Plasmacytoma | 1 | 1997 | 171 | 0.030 |
Why?
|
Area Under Curve | 2 | 2011 | 1638 | 0.030 |
Why?
|
Dura Mater | 1 | 1998 | 292 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2021 | 1733 | 0.030 |
Why?
|
Hepatitis, Viral, Human | 1 | 2016 | 141 | 0.030 |
Why?
|
Circle of Willis | 1 | 2015 | 77 | 0.030 |
Why?
|
Radionuclide Imaging | 2 | 1998 | 1986 | 0.030 |
Why?
|
Oxygen | 2 | 2024 | 4251 | 0.030 |
Why?
|
Anterior Cerebral Artery | 1 | 2015 | 50 | 0.030 |
Why?
|
Infant | 7 | 2019 | 36461 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2002 | 1028 | 0.030 |
Why?
|
Curriculum | 2 | 2021 | 3783 | 0.030 |
Why?
|
Adenoma, Islet Cell | 1 | 1995 | 72 | 0.030 |
Why?
|
Olfaction Disorders | 1 | 1997 | 225 | 0.030 |
Why?
|
DiGeorge Syndrome | 1 | 1996 | 187 | 0.030 |
Why?
|
Aortic Diseases | 1 | 2021 | 741 | 0.030 |
Why?
|
Causality | 2 | 2012 | 1252 | 0.030 |
Why?
|
Medicare Payment Advisory Commission | 1 | 2014 | 14 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 814 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2016 | 527 | 0.030 |
Why?
|
Gallbladder | 1 | 2016 | 308 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3432 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2023 | 2474 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2020 | 904 | 0.030 |
Why?
|
Dapsone | 1 | 1994 | 55 | 0.030 |
Why?
|
Gastric Acid | 1 | 1994 | 98 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1110 | 0.030 |
Why?
|
Unconsciousness | 1 | 2016 | 252 | 0.030 |
Why?
|
Antacids | 1 | 1994 | 94 | 0.030 |
Why?
|
Thalamic Diseases | 1 | 2013 | 15 | 0.030 |
Why?
|
Infusions, Intravenous | 2 | 2012 | 2228 | 0.030 |
Why?
|
Autopsy | 1 | 2018 | 1011 | 0.030 |
Why?
|
Liability, Legal | 1 | 2015 | 209 | 0.030 |
Why?
|
Needs Assessment | 1 | 2020 | 1140 | 0.030 |
Why?
|
Telephone | 1 | 2017 | 629 | 0.030 |
Why?
|
Research Design | 1 | 2009 | 6207 | 0.030 |
Why?
|
Management Audit | 1 | 2013 | 23 | 0.030 |
Why?
|
Encephalitis, Viral | 1 | 2013 | 58 | 0.030 |
Why?
|
Electroencephalography | 3 | 2020 | 6282 | 0.030 |
Why?
|
Outpatients | 1 | 2021 | 1596 | 0.030 |
Why?
|
Necrosis | 2 | 2010 | 1616 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 1994 | 400 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1555 | 0.030 |
Why?
|
Boston | 3 | 2011 | 9346 | 0.030 |
Why?
|
Pancreatic Neoplasms | 2 | 2005 | 5444 | 0.030 |
Why?
|
Writing | 1 | 2015 | 200 | 0.030 |
Why?
|
Emergencies | 1 | 2019 | 1223 | 0.030 |
Why?
|
Vasodilation | 1 | 1997 | 969 | 0.030 |
Why?
|
Government Agencies | 1 | 2013 | 161 | 0.030 |
Why?
|
Prisoners | 1 | 2016 | 315 | 0.030 |
Why?
|
Epirubicin | 2 | 2003 | 82 | 0.030 |
Why?
|
Temporal Lobe | 1 | 2000 | 1716 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2012 | 5861 | 0.030 |
Why?
|
Smoke Inhalation Injury | 1 | 2012 | 47 | 0.030 |
Why?
|
Age Distribution | 2 | 2009 | 2869 | 0.030 |
Why?
|
Breast Neoplasms | 3 | 2007 | 21162 | 0.030 |
Why?
|
Diplopia | 1 | 2014 | 217 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2000 | 1029 | 0.020 |
Why?
|
Alberta | 1 | 2012 | 67 | 0.020 |
Why?
|
Sarcoidosis | 1 | 1997 | 535 | 0.020 |
Why?
|
Hippocampus | 1 | 2024 | 3776 | 0.020 |
Why?
|
Hypercalcemia | 1 | 1995 | 425 | 0.020 |
Why?
|
Risk Assessment | 5 | 2012 | 24295 | 0.020 |
Why?
|
Decision Trees | 1 | 2013 | 508 | 0.020 |
Why?
|
Mitral Valve | 1 | 2000 | 1473 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2005 | 1377 | 0.020 |
Why?
|
Cost Control | 1 | 2013 | 628 | 0.020 |
Why?
|
Family | 1 | 2022 | 3209 | 0.020 |
Why?
|
Hysterosalpingography | 1 | 2010 | 26 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2013 | 15831 | 0.020 |
Why?
|
Adrenal Gland Diseases | 1 | 2011 | 141 | 0.020 |
Why?
|
Accreditation | 1 | 2014 | 476 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 652 | 0.020 |
Why?
|
Anisotropy | 2 | 2004 | 1285 | 0.020 |
Why?
|
Diagnostic Tests, Routine | 1 | 1996 | 789 | 0.020 |
Why?
|
Oligomenorrhea | 1 | 2010 | 42 | 0.020 |
Why?
|
Movement | 1 | 2017 | 1468 | 0.020 |
Why?
|
Vision Disorders | 1 | 1997 | 1090 | 0.020 |
Why?
|
Radiotherapy | 2 | 2010 | 1497 | 0.020 |
Why?
|
Health Care Rationing | 1 | 2013 | 435 | 0.020 |
Why?
|
Psychomotor Agitation | 1 | 2012 | 307 | 0.020 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2012 | 564 | 0.020 |
Why?
|
Spinal Cord | 2 | 2011 | 1811 | 0.020 |
Why?
|
Lung | 2 | 2021 | 10067 | 0.020 |
Why?
|
Putamen | 1 | 2011 | 288 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2011 | 618 | 0.020 |
Why?
|
Sella Turcica | 1 | 2010 | 117 | 0.020 |
Why?
|
Adrenalectomy | 1 | 2011 | 347 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
Washington | 1 | 2010 | 315 | 0.020 |
Why?
|
Caudate Nucleus | 1 | 2011 | 388 | 0.020 |
Why?
|
Neural Pathways | 1 | 2020 | 3079 | 0.020 |
Why?
|
Hospital Information Systems | 1 | 1972 | 395 | 0.020 |
Why?
|
Neurosurgery | 1 | 2016 | 682 | 0.020 |
Why?
|
Urokinase-Type Plasminogen Activator | 1 | 2010 | 324 | 0.020 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2011 | 181 | 0.020 |
Why?
|
Computers | 1 | 1972 | 589 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4860 | 0.020 |
Why?
|
Delirium | 1 | 2021 | 1698 | 0.020 |
Why?
|
Hypoglycemia | 1 | 2016 | 896 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2727 | 0.020 |
Why?
|
Jugular Veins | 1 | 2010 | 211 | 0.020 |
Why?
|
Headache Disorders, Primary | 1 | 2009 | 39 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2519 | 0.020 |
Why?
|
Disease Vectors | 1 | 2008 | 61 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2126 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2016 | 3609 | 0.020 |
Why?
|
Thymoma | 1 | 1990 | 186 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2019 | 2418 | 0.020 |
Why?
|
Health Services | 1 | 1993 | 755 | 0.020 |
Why?
|
Endometrium | 1 | 2010 | 406 | 0.020 |
Why?
|
Thymus Neoplasms | 1 | 1990 | 272 | 0.020 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2014 | 1089 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2019 | 1535 | 0.020 |
Why?
|
Myasthenia Gravis | 1 | 1990 | 214 | 0.020 |
Why?
|
Fluorouracil | 2 | 2003 | 1651 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 2011 | 873 | 0.020 |
Why?
|
Catheterization, Peripheral | 1 | 2010 | 346 | 0.020 |
Why?
|
Cyclophosphamide | 2 | 2003 | 2234 | 0.020 |
Why?
|
Cranial Nerve Diseases | 1 | 2007 | 111 | 0.020 |
Why?
|
Brain Mapping | 1 | 2001 | 6596 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2009 | 592 | 0.020 |
Why?
|
Weight Loss | 1 | 2017 | 2712 | 0.020 |
Why?
|
Logistic Models | 2 | 2011 | 13278 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2010 | 391 | 0.020 |
Why?
|
Bacterial Infections | 2 | 2008 | 1390 | 0.020 |
Why?
|
Kidney Diseases, Cystic | 1 | 1967 | 182 | 0.020 |
Why?
|
Paralysis | 1 | 2007 | 250 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2001 | 26389 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2012 | 2120 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5789 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2018 | 3070 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14762 | 0.020 |
Why?
|
Reference Standards | 1 | 2009 | 1010 | 0.020 |
Why?
|
Radiopharmaceuticals | 2 | 2010 | 2704 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2019 | 2929 | 0.020 |
Why?
|
Aspartic Acid | 1 | 2007 | 575 | 0.020 |
Why?
|
Hemodynamics | 1 | 2014 | 4188 | 0.010 |
Why?
|
Attitude to Health | 1 | 1993 | 2021 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1403 | 0.010 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 872 | 0.010 |
Why?
|
Radiotherapy, High-Energy | 1 | 2004 | 228 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2008 | 1527 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1972 | 1203 | 0.010 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3824 | 0.010 |
Why?
|
Microcirculation | 1 | 2008 | 1282 | 0.010 |
Why?
|
Hyperoxia | 1 | 2005 | 259 | 0.010 |
Why?
|
Blood Pressure | 1 | 1998 | 8533 | 0.010 |
Why?
|
Postoperative Period | 1 | 2007 | 1824 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2004 | 616 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13643 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4427 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1998 | 1622 | 0.010 |
Why?
|
Virus Diseases | 1 | 2008 | 720 | 0.010 |
Why?
|
Lactic Acid | 1 | 2007 | 1139 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2057 | 0.010 |
Why?
|
Incidence | 2 | 2011 | 21525 | 0.010 |
Why?
|
Survival Analysis | 2 | 2005 | 10100 | 0.010 |
Why?
|
Alcoholism | 1 | 2012 | 1980 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3957 | 0.010 |
Why?
|
Aging | 2 | 2008 | 8731 | 0.010 |
Why?
|
Pregnancy | 2 | 2009 | 30237 | 0.010 |
Why?
|
Wound Healing | 1 | 2012 | 2800 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8351 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6214 | 0.010 |
Why?
|
Leukocyte Count | 1 | 2005 | 1606 | 0.010 |
Why?
|
Cough | 1 | 2005 | 599 | 0.010 |
Why?
|
Antigens, Viral | 1 | 2005 | 995 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2012 | 2077 | 0.010 |
Why?
|
Antibodies, Bacterial | 1 | 2007 | 1477 | 0.010 |
Why?
|
Age Factors | 2 | 2012 | 18397 | 0.010 |
Why?
|
Central Nervous System | 1 | 2007 | 1345 | 0.010 |
Why?
|
Brain Stem Infarctions | 1 | 1999 | 31 | 0.010 |
Why?
|
Cerebral Arterial Diseases | 1 | 1999 | 82 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 2007 | 1172 | 0.010 |
Why?
|
Decision Making | 1 | 1993 | 3951 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 1993 | 3230 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10384 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2012 | 11061 | 0.010 |
Why?
|
Subdural Effusion | 1 | 1998 | 19 | 0.010 |
Why?
|
Indium Radioisotopes | 1 | 1998 | 114 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2004 | 2921 | 0.010 |
Why?
|
Blood Patch, Epidural | 1 | 1998 | 57 | 0.010 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2001 | 646 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 678 | 0.010 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2001 | 614 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2003 | 10745 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30213 | 0.010 |
Why?
|
Epidural Space | 1 | 1998 | 123 | 0.010 |
Why?
|
Paranasal Sinus Diseases | 1 | 1997 | 121 | 0.010 |
Why?
|
Central Nervous System Neoplasms | 1 | 2005 | 926 | 0.010 |
Why?
|
Pain | 2 | 2007 | 5098 | 0.010 |
Why?
|
Databases, Factual | 1 | 2012 | 8066 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2007 | 2903 | 0.010 |
Why?
|
Ischemia | 1 | 2005 | 1905 | 0.010 |
Why?
|
Schistosoma mansoni | 1 | 1997 | 156 | 0.010 |
Why?
|
Spinal Cord Neoplasms | 1 | 1998 | 263 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 1996 | 348 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6259 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7475 | 0.010 |
Why?
|
Emergency Medicine | 1 | 2004 | 1220 | 0.010 |
Why?
|
Water | 1 | 2001 | 1417 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2005 | 4891 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2003 | 3552 | 0.010 |
Why?
|
Posture | 1 | 1998 | 955 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4784 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2001 | 4853 | 0.010 |
Why?
|
Parathyroid Hormone-Related Protein | 1 | 1995 | 327 | 0.010 |
Why?
|
Patient Compliance | 1 | 2003 | 2694 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2004 | 8540 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1996 | 1384 | 0.010 |
Why?
|
Kidney | 1 | 1967 | 7074 | 0.010 |
Why?
|
Gastric Mucosa | 1 | 1994 | 602 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 1998 | 1043 | 0.010 |
Why?
|
Drug Interactions | 1 | 1994 | 1419 | 0.010 |
Why?
|
Thymectomy | 1 | 1990 | 200 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1996 | 1424 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2001 | 3561 | 0.000 |
Why?
|
Parathyroid Hormone | 1 | 1995 | 1791 | 0.000 |
Why?
|
Cross-Over Studies | 1 | 1994 | 2108 | 0.000 |
Why?
|
Odds Ratio | 1 | 2000 | 9661 | 0.000 |
Why?
|
Disease | 1 | 1993 | 675 | 0.000 |
Why?
|
Echocardiography | 1 | 1999 | 5037 | 0.000 |
Why?
|
Heart Diseases | 1 | 1999 | 2817 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1998 | 5306 | 0.000 |
Why?
|
Neurologic Manifestations | 1 | 1966 | 18 | 0.000 |
Why?
|
Cleidocranial Dysplasia | 1 | 1966 | 18 | 0.000 |
Why?
|
Aortography | 1 | 1967 | 423 | 0.000 |
Why?
|
Fear | 1 | 1993 | 1496 | 0.000 |
Why?
|
Neoplasm Proteins | 1 | 1995 | 3601 | 0.000 |
Why?
|
Atrial Fibrillation | 1 | 2001 | 5182 | 0.000 |
Why?
|
Adaptation, Psychological | 1 | 1993 | 2662 | 0.000 |
Why?
|
Proteins | 1 | 1995 | 6002 | 0.000 |
Why?
|
Chronic Disease | 1 | 1993 | 9357 | 0.000 |
Why?
|
Kidney Diseases | 1 | 1967 | 2101 | 0.000 |
Why?
|